Antimicrobial Resistance Surveillance Market Size

Antimicrobial Resistance Surveillance Market Size

Antimicrobial Resistance Surveillance Market size was valued at USD 5.9 billion in 2023 and is estimated to expand at around 5.8% CAGR from 2024 to 2032. Antimicrobial resistance surveillance refers to the systematic and ongoing monitoring of the prevalence and patterns of antimicrobial resistance (AMR) in various pathogens, including bacteria, viruses, fungi, and parasites. This surveillance is crucial for understanding how resistant these pathogens are to the drugs that are typically used to treat infections they cause.

The rising incidence of antimicrobial resistance has become a significant public health concern globally. For instance, according to the LANCET, antimicrobial resistance contributes to about 7,00,000 deaths annually, and without effective intervention these are projected to cause 10 million deaths by 2050. Thus, as the prevalence of antimicrobial resistance continue to rise, there is a growing demand for effective strategies in managing and addressing this issue, including advanced measures for surveillance, prevention, and appropriate use of antimicrobial agents.
 

Additionally, rising awareness and screening programs, increasing prevalence of infectious diseases, growing infectious disease diagnostics which is estimated to reach USD 40 billion by 2032, and advancements in screening technologies, are among other contributing factors escalating the growth of the market.